CHLORTHALIDONE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Chlorthalidone, and when can generic versions of Chlorthalidone launch?
Chlorthalidone is a drug marketed by Abbott, Ajanta Pharma Ltd, Alembic, Alkem Labs Ltd, Amneal Pharms Co, Ani Pharms, Appco, Ascot, Barr Labs Inc, Chartwell Rx, Cosette, Dava Pharms Inc, Inventia, Ivax Pharms, Kv Pharm, Mankind Pharma, Mutual Pharm, Mylan, Novast Labs, Pioneer Pharms, Purepac Pharm, Sandoz, Sun Pharm Industries, Sunny, Superpharm, Tagi, Umedica, Unichem, Usl Pharma, Vangard, Warner Chilcott, Watson Labs, and Zydus Pharms. and is included in fifty-eight NDAs.
The generic ingredient in CHLORTHALIDONE is chlorthalidone. There are twenty-one drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the chlorthalidone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Chlorthalidone
A generic version of CHLORTHALIDONE was approved as chlorthalidone by SUN PHARM INDUSTRIES on July 21st, 1986.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CHLORTHALIDONE?
- What are the global sales for CHLORTHALIDONE?
- What is Average Wholesale Price for CHLORTHALIDONE?
Summary for CHLORTHALIDONE
![CHLORTHALIDONE drug patent expirations Drug patent expirations by year for CHLORTHALIDONE](/p/graph/s/t/CHLORTHALIDONE-patent-expirations.png)
![Drug Prices for CHLORTHALIDONE](/p/graph/drug-price/CHLORTHALIDONE.png)
See drug prices for CHLORTHALIDONE
![Drug Sales Revenue Trends for CHLORTHALIDONE](/p/graph/drug-sales-revenues/CHLORTHALIDONE.png)
Recent Clinical Trials for CHLORTHALIDONE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Jessa Hospital | Phase 4 |
Vrije Universiteit Brussel | Phase 4 |
Roche Diagnostics | Phase 4 |
Pharmacology for CHLORTHALIDONE
Drug Class | Thiazide-like Diuretic |
Physiological Effect | Increased Diuresis |